The former shareholder of a pharmaceutical business owes additional tax on a portion of its $191 million settlement payout following a squeeze-out merger, after the Third Circuit determined Thursday that the shareholder couldn’t convert what was ordinary income into capital gains.
John Woolley is a Multimedia Executive Editor. He covers topics related to lawsuits and federal legislation, showcasing his expertise in legal matters. John has been featured in Deseret News, Bloomberg Law, Pinsent Masons, Hancock Whitney, and The Georgetown Voice.



